PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för sofosbuvir. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

17 hits

Bibliografisk träff 2015-04-01

Sofosbuvir for chronic hepatitis C virus infection genotype 1-4 in patients coinfected with HIV.

Rodriguez-Torres M, Gaggar A, Shen G, Kirby B, Svarovskaia E, Brainard D, Symonds WT, McHutchison JG, Gonzalez M, Rodriguez-Orengo J.

J Acquir Immune Defic Syndr · clinical trial, phase ii; research support, non-u.s. gov't; journal article · DOI 10.1097/qai.0000000000000516

Bibliografisk träff 2015-03-10

All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study.

Nelson DR, Cooper JN, Lalezari JP, Lawitz E, Pockros PJ, Gitlin N, Freilich BF, Younes ZH, Harlan W, Ghalib R, Oguchi G, Thuluvath PJ, Ortiz-Lasanta G, Rabinovitz M, Bernstein D, Bennett M, Hawkins T, Ravendhran N, Sheikh AM, Varunok P, Kowdley KV, Hennicken D, McPhee F, Rana K, Hughes EA, ALLY-3 Study Team.

Hepatology · clinical trial, phase iii; research support, non-u.s. gov't; research-article; journal article · DOI 10.1002/hep.27726

Bibliografisk träff 2015-02-23

Response letter: Just a matter of luck?

Donato MF, Malinverno F, Monico S.

Liver Int · letter; comment · DOI 10.1111/liv.12804

Bibliografisk träff 2015-02-09

Optimal duration of pre-liver transplantation anti-hepatitis C virus treatment with direct-acting agent sofosbuvir.

Borentain P, Colson P, Darque A, Gérolami R.

Liver Int · letter; comment · DOI 10.1111/liv.12789

Bibliografisk träff 2015-02-04

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study.

Molina JM, Orkin C, Iser DM, Zamora FX, Nelson M, Stephan C, Massetto B, Gaggar A, Ni L, Svarovskaia E, Brainard D, Subramanian GM, McHutchison JG, Puoti M, Rockstroh JK, PHOTON-2 study team.

Lancet · clinical trial, phase iii; research support, non-u.s. gov't; multicenter study; journal article · DOI 10.1016/s0140-6736(14)62483-1

Bibliografisk träff 2015-02-03

Assessing safety and efficacy of sofosbuvir for the treatment of hepatitis C.

D'Ambrosio R, Aghemo A, Colombo M.

Expert Opin Drug Saf · research support, non-u.s. gov't; review; journal article · DOI 10.1517/14740338.2015.1009035

Bibliografisk träff 2015-02-01

What is the role of sofosbuvir in treating hepatitis C infection?

Carey L.

JAAPA · journal article · DOI 10.1097/01.jaa.0000459818.09661.c0

Bibliografisk träff 2015-02-01

Ledipasvir and sofosbuvir: Interferon free therapy for hepatitis C virus genotype 1 infection.

Waheed Y.

World J Virol · letter; journal article · DOI 10.5501/wjv.v4.i1.33

Bibliografisk träff 2015-01-31

Sofosbuvir and simeprevir combination therapy in the setting of liver transplantation and hemodialysis.

Perumpail RB, Wong RJ, Ha LD, Pham EA, Wang U, Luong H, Kumari R, Daugherty TJ, Higgins JP, Younossi ZM, Kim WR, Glenn JS, Ahmed A.

Transpl Infect Dis · journal article; case reports · DOI 10.1111/tid.12348

Bibliografisk träff 2015-01-30

Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis.

Lawitz E, Poordad F, Brainard DM, Hyland RH, An D, Dvory-Sobol H, Symonds WT, McHutchison JG, Membreno FE.

Hepatology · clinical trial, phase ii; research support, non-u.s. gov't; research-article; journal article · DOI 10.1002/hep.27567

Bibliografisk träff 2015-01-28

A Cross-Sectional Study Comparing the Frequency of Drug Interactions After Adding Simeprevir- or Sofosbuvir-Containing Therapy to Medication Profiles of Hepatitis C Monoinfected Patients.

Patel N, Nasiri M, Koroglu A, Bliss S, Davis M, McNutt LA, Miller C.

Infect Dis Ther · research-article; journal article · DOI 10.1007/s40121-015-0058-x

Bibliografisk träff 2015-01-16

Simeprevir and sofosbuvir for treatment of chronic hepatitis C infection.

Childs-Kean LM, Hand EO.

Clin Ther · review; journal article · DOI 10.1016/j.clinthera.2014.12.012

Bibliografisk träff 2015-01-12

Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes.

Younossi ZM, Stepanova M, Sulkowski M, Naggie S, Puoti M, Orkin C, Hunt SL.

J Infect Dis · clinical trial, phase iii; research support, non-u.s. gov't; research-article; journal article · DOI 10.1093/infdis/jiv005

Bibliografisk träff 2014-11-20

Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvir.

Donaldson EF, Harrington PR, O'Rear JJ, Naeger LK.

Hepatology · journal article · DOI 10.1002/hep.27375

Bibliografisk träff 2014-10-07

Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.

Charlton M, Gane E, Manns MP, Brown RS, Curry MP, Kwo PY, Fontana RJ, Gilroy R, Teperman L, Muir AJ, McHutchison JG, Symonds WT, Brainard D, Kirby B, Dvory-Sobol H, Denning J, Arterburn S, Samuel D, Forns X, Terrault NA.

Gastroenterology · clinical trial; research support, non-u.s. gov't; multicenter study; journal article · DOI 10.1053/j.gastro.2014.10.001

Bibliografisk träff 2014-09-29

Successful treatment of fibrosing cholestatic hepatitis with pegylated interferon, ribavirin and sofosbuvir after a combined kidney-liver transplantation.

Delabaudière C, Lavayssière L, Dörr G, Muscari F, Danjoux M, Sallusto F, Peron JM, Bureau C, Rostaing L, Izopet J, Kamar N.

Transpl Int · journal article; case reports · DOI 10.1111/tri.12428

Bibliografisk träff 2014-09-28

Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.

Curry MP, Forns X, Chung RT, Terrault NA, Brown R, Fenkel JM, Gordon F, O'Leary J, Kuo A, Schiano T, Everson G, Schiff E, Befeler A, Gane E, Saab S, McHutchison JG, Subramanian GM, Symonds WT, Denning J, McNair L, Arterburn S, Svarovskaia E, Moonka D, Afdhal N.

Gastroenterology · clinical trial, phase ii; research support, non-u.s. gov't; multicenter study; journal article · DOI 10.1053/j.gastro.2014.09.023